These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 1963808)

  • 1. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W; Hönack D
    Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imidazenil: a new partial positive allosteric modulator of gamma-aminobutyric acid (GABA) action at GABAA receptors.
    Giusti P; Ducić I; Puia G; Arban R; Walser A; Guidotti A; Costa E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1018-28. PubMed ID: 8394902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.
    Knoflach F; Benke D; Wang Y; Scheurer L; Lüddens H; Hamilton BJ; Carter DB; Mohler H; Benson JA
    Mol Pharmacol; 1996 Nov; 50(5):1253-61. PubMed ID: 8913357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
    Jenck F; Moreau JL; Bonetti EP; Martin JR; Haefely WE
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor.
    Langen B; Egerland U; Bernöster K; Dost R; Unverferth K; Rundfeldt C
    J Pharmacol Exp Ther; 2005 Aug; 314(2):717-24. PubMed ID: 15860576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The affinities, potencies and efficacies of some benzodiazepine-receptor agonists, antagonists and inverse-agonists at rat hippocampal GABAA-receptors.
    Kemp JA; Marshall GR; Wong EH; Woodruff GN
    Br J Pharmacol; 1987 Jul; 91(3):601-8. PubMed ID: 3038246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non-human primates.
    Brouillet E; Chavoix C; Bottlaender M; Khalili-Varasteh M; Hantraye P; Fournier D; Dodd RH; Mazière M
    Brain Res; 1991 Aug; 557(1-2):167-76. PubMed ID: 1660750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labelling of diazepam-sensitive and -insensitive benzodiazepine receptors with [3H]tert-butyl-8-chloro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo [1,5-a][1,4]benzodiazepine 3-carboxylate (ZG-63).
    Wong G; Gu ZQ; de Costa B; Skolnick P
    Eur J Pharmacol; 1993 Sep; 247(1):57-63. PubMed ID: 8258361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
    Facklam M; Schoch P; Bonetti EP; Jenck F; Martin JR; Moreau JL; Haefely WE
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1113-21. PubMed ID: 1318371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.
    Bernard PS; Bennett DA; Pastor G; Yokoyama N; Liebman JM
    J Pharmacol Exp Ther; 1985 Oct; 235(1):98-105. PubMed ID: 2995650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
    Serra M; Ghiani CA; Motzo C; Cuccheddu T; Floris S; Giusti P; Biggio G
    J Pharmacol Exp Ther; 1994 Apr; 269(1):32-8. PubMed ID: 8169838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
    Löscher W; Potschka H; Rieck S; Tipold A; Rundfeldt C
    Epilepsia; 2004 Oct; 45(10):1228-39. PubMed ID: 15461677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
    Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereospecific transduction of behavioral effects via diazepam-insensitive GABAA receptors.
    Acri JB; Wong G; Witkin JM
    Eur J Pharmacol; 1995 May; 278(3):213-23. PubMed ID: 7589157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice?
    Mirza NR; Nielsen EØ
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1378-85. PubMed ID: 16352707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.